The first stop for professional medicines advice

Budesonide

Published
Topics: BudesonideCCG commissioned new medicinesEar, nose and throat disorders · Gastrointestinal disordersNew MedicinesRespiratory disordersSafety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Articles
  3. Medicine Compliance Aid Stability
    1. Entocort · Tillotts Pharma
    2. Budenofalk · Dr Falk Pharma UK Ltd
  4. Lactation Safety Information
    1. Inhalation
    2. Intranasal
    3. Oral/rectal · for inflammatory bowel disease

dm+d

108622005

Articles

Using oral or parenteral corticosteroids during breastfeeding

17 July 2023

Using inhaled or topical corticosteroids during breastfeeding

17 July 2023

Compatibility of nebuliser solution combinations

22 June 2022Guidance on what to consider when mixing nebuliser solutions and advice on which combinations are compatible.

Example medicines to prescribe by brand name in primary care

27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.
Search Articles

Medicine Compliance Aid Stability

EntocortTillotts Pharma

Tillotts Pharma
Entocort
Capsules 3mg e/c m/r granules
A1 · Amber 1Stability data is available in an alternative container (not CAs) that may be extrapolated to support storage in CAs.
Airtight container
Protect from light
Protect from moisture
Protect from light and store in airtight containers. SPC states store in original packaging, which contains a desiccant. Company have stability studies that demonstrate stability in open storage for 3 months
1 November 2022
Usage of Medicines in Compliance Aids

BudenofalkDr Falk Pharma UK Ltd

Dr Falk Pharma UK Ltd
Budenofalk
Capsules 3mg e/c granules
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light and store in airtight containers.
1 November 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Inhalation

Inhalation
Yes
-
Limited published evidence of safety
Only negligible amounts in breast milk
Used in infants >1 month
Safety in Lactation: Drugs for obstructive airways disease
18 September 2020
Bibliography

Intranasal

Intranasal
Yes
Safety in Lactation: Drugs used in nasal allergy
18 September 2020
Bibliography

Oral/rectal for inflammatory bowel disease

Oral/rectal
for inflammatory bowel disease
Yes
-
No published evidence of safety after oral or rectal administration
Low levels anticipated in milk due to the drug’s properties
Safety in lactation: Drugs for chronic bowel disorders
18 September 2020
Bibliography